CRNX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.90%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $898,422.58

Crinetics Pharmaceuticals Insider Trading History Chart

Crinetics Pharmaceuticals Share Price & Price History

^$21.85

▲ +0.02 (0.09%)

As of 06/1/2023 01:00 AM ET

Days: 30 | 90 | 365

27 U.S. Cities Where Stocks Yield 26% a Year

From Investing Daily | Ad

What’s the highest-yielding stock you’ve ever owned?

The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.

Get in on the action here.

Crinetics Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/5/2023	Dana Pizzuti	Insider	Sell	8,212	$16.15	$132,623.80	4,500
1/25/2023	Stephen F. Betz	Insider	Sell	8,336	$21.07	$175,639.52	67,815
1/17/2023	Stephen F. Betz	Insider	Sell	3,126	$18.00	$56,268.00	76,151
12/15/2022	Stephen F. Betz	Insider	Sell	3,126	$16.00	$50,016.00	82,403
12/1/2022	Stephen F. Betz	Insider	Sell	3,126	$17.84	$55,767.84	84,968
11/15/2022	Stephen F. Betz	Insider	Sell	3,126	$18.72	$58,518.72	88,094
10/17/2022	Stephen F. Betz	Insider	Sell	3,126	$17.73	$55,423.98	94,346
10/3/2022	Stephen F. Betz	Insider	Sell	3,126	$19.64	$61,394.64	97,472
9/15/2022	Stephen F. Betz	Insider	Sell	4,168	$21.01	$87,569.68	100,598
9/7/2022	Stephen F. Betz	Insider	Sell	1,042	$21.00	$21,882.00	104,766
7/26/2022	Jeff E Knight	COO	Sell	1,152	$20.70	$23,846.40	4,950
7/13/2022	Matthew K. Fust	Director	Sell	5,700	$20.96	$119,472.00	12,536
5/2/2022	Stephen F. Betz	Insider	Sell	3,247	$20.10	$65,264.70	107,598
4/18/2022	Perceptive Advisors Llc	Major Shareholder	Buy	157,515	$22.22	$3,499,983.30	5,321,032
4/18/2022	Stephen F. Betz	Insider	Sell	5,664	$25.81	$146,187.84	110,845
4/13/2022	Richard Scott Struthers	CEO	Sell	138,643	$26.83	$3,719,791.69	730,805
4/5/2022	Richard Scott Struthers	CEO	Sell	21,357	$25.34	$541,186.38	57,400
4/4/2022	Stephen F. Betz	Insider	Sell	9,000	$23.97	$215,730.00	116,509
3/31/2022	Stephen F. Betz	Insider	Sell	4,164	$21.06	$87,693.84
3/1/2022	Stephen F. Betz	Insider	Sell	3,123	$19.73	$61,616.79
2/7/2022	Ajay Madan	Insider	Sell	13,411	$17.83	$239,118.13
2/1/2022	Stephen F. Betz	Insider	Sell	3,123	$18.79	$58,681.17
1/18/2022	Stephen F. Betz	Insider	Sell	4,168	$23.29	$97,072.72
1/3/2022	Stephen F. Betz	Insider	Sell	7,168	$28.02	$200,847.36
12/28/2021	Stephen F. Betz	Insider	Sell	3,000	$27.95	$83,850.00
12/15/2021	Stephen F. Betz	Insider	Sell	5,668	$24.14	$136,825.52
12/1/2021	Stephen F. Betz	Insider	Sell	5,668	$27.38	$155,189.84
11/8/2021	Stephen F. Betz	Insider	Sell	3,900	$28.42	$110,838.00
11/5/2021	Stephen F. Betz	Insider	Sell	12,600	$27.95	$352,170.00
11/1/2021	Matthew K. Fust	Director	Sell	8,954	$25.50	$228,327.00
11/1/2021	Stephen F. Betz	Insider	Sell	5,668	$24.79	$140,509.72
10/27/2021	Stephen F. Betz	Insider	Sell	3,000	$24.00	$72,000.00
10/25/2021	Perceptive Advisors Llc	Major Shareholder	Buy	1,200,000	$19.80	$23,760,000.00
10/21/2021	Stephen F. Betz	Insider	Sell	1,042	$21.10	$21,986.20
9/8/2021	Matthew K. Fust	Director	Sell	6,046	$25.50	$154,173.00	18,582
9/7/2021	Richard Scott Struthers	CEO	Sell	30,000	$25.00	$750,000.00
7/26/2021	Matthew K. Fust	Director	Sell	5,000	$19.59	$97,950.00
7/19/2021	Matthew K. Fust	Director	Sell	5,000	$19.50	$97,500.00	17,536
7/12/2021	Matthew K. Fust	Director	Sell	5,000	$20.71	$103,550.00
4/8/2021	Perceptive Advisors Llc	Major Shareholder	Buy	304,136	$16.44	$4,999,995.84
12/2/2020	Richard Scott Struthers	CEO	Buy	1,000	$12.60	$12,600.00	4,000
7/15/2020	Richard Scott Struthers	CEO	Sell	17,500	$15.30	$267,750.00

Graphite versus Lithium - What Investors Should Know

From Edge On The Street | Ad

Over 18 million EVs will be cruising U.S roads by 2030. And every one million EVs manufactured will require 82,000 tons of the metal graphite for their batteries. That's a total of 1,476,000 tons of graphite! Graphite is actually the largest component of EV batteries - NOT lithium. Experts warn of a massive graphite shortfall, especially since North America currently has no operating graphite mines.

See why graphite could be the "new lithium"

SEC Filings (Institutional Ownership Changes) for Crinetics Pharmaceuticals (NASDAQ:CRNX)

95.64% of Crinetics Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Crinetics Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/18/2023	JPMorgan Chase & Co.	40,513	$0.65M	0.0%	+16.8%	0.075%
5/18/2023	New York State Common Retirement Fund	28,764	$0.46M	0.0%	-26.5%	0.053%
5/16/2023	Perceptive Advisors LLC	3,554,887	$57.09M	1.7%	-12.0%	6.580%
5/16/2023	Susquehanna International Group LLP	61,987	$1M	0.0%	+505.6%	0.115%
5/16/2023	Sphera Funds Management LTD.	82,747	$1.33M	0.2%	-87.7%	0.153%
5/16/2023	State Street Corp	2,218,794	$35.63M	0.0%	+10.7%	4.107%
5/16/2023	Saturn V Capital Management LLC	741,043	$11.90M	8.9%	+18.8%	1.372%
5/16/2023	First Light Asset Management LLC	1,619,125	$26M	2.3%	+21.8%	2.997%
5/16/2023	Geode Capital Management LLC	954,860	$15.34M	0.0%	+3.7%	1.767%
5/16/2023	Altium Capital Management LP	100,000	$1.61M	0.9%	N/A	0.185%
5/15/2023	Schonfeld Strategic Advisors LLC	73,890	$1.19M	0.0%	N/A	0.137%
5/15/2023	Braidwell LP	2,019,714	$32.44M	1.1%	-41.8%	3.738%
5/15/2023	Two Sigma Advisers LP	60,300	$0.97M	0.0%	-39.3%	0.112%
5/15/2023	Two Sigma Investments LP	32,200	$0.52M	0.0%	+30.8%	0.060%
5/15/2023	Deutsche Bank AG	38,319	$0.62M	0.0%	+31.0%	0.071%
5/15/2023	Price T Rowe Associates Inc. MD	41,783	$0.67M	0.0%	-19.5%	0.077%
5/15/2023	Atom Investors LP	12,886	$0.21M	0.1%	-84.2%	0.024%
5/12/2023	BlackRock Inc.	3,956,358	$63.54M	0.0%	+1.0%	7.327%
5/12/2023	BNP Paribas Arbitrage SNC	58,788	$0.94M	0.0%	+112.7%	0.109%
5/12/2023	Bank of America Corp DE	176,473	$2.83M	0.0%	+42.2%	0.327%
5/12/2023	Finepoint Capital LP	868,427	$13.95M	5.3%	+5.6%	1.608%
5/12/2023	Franklin Resources Inc.	138,530	$2.23M	0.0%	N/A	0.257%
5/12/2023	UBS Group AG	59,168	$0.95M	0.0%	-26.7%	0.110%
5/12/2023	Martingale Asset Management L P	48,180	$0.77M	0.0%	+5.5%	0.089%
5/12/2023	Dimensional Fund Advisors LP	449,605	$7.22M	0.0%	-11.6%	0.833%
5/12/2023	Wellington Management Group LLP	3,635,526	$58.39M	0.0%	+29.6%	6.733%
5/12/2023	First Republic Investment Management Inc.	19,761	$0.32M	0.0%	+2.8%	0.037%
5/12/2023	Charles Schwab Investment Management Inc.	345,567	$5.55M	0.0%	+0.7%	0.640%
5/12/2023	Profund Advisors LLC	24,403	$0.39M	0.0%	N/A	0.045%
5/11/2023	FMR LLC	920,958	$14.79M	0.0%	-51.1%	1.706%
5/11/2023	ExodusPoint Capital Management LP	147,116	$2.36M	0.0%	N/A	0.272%
5/11/2023	Natixis Advisors L.P.	20,222	$0.33M	0.0%	+71.9%	0.037%
5/11/2023	Rhumbline Advisers	81,904	$1.32M	0.0%	+3.7%	0.152%
5/11/2023	Citigroup Inc.	103,817	$1.67M	0.0%	+112.4%	0.192%
5/10/2023	Credit Suisse AG	31,720	$0.51M	0.0%	+6.9%	0.059%
5/10/2023	Swiss National Bank	81,300	$1.31M	0.0%	-10.5%	0.151%
5/10/2023	Tekla Capital Management LLC	78,529	$1.26M	0.0%	+71.2%	0.145%
5/9/2023	Principal Financial Group Inc.	13,988	$0.23M	0.0%	+13.4%	0.026%
5/9/2023	Tower Research Capital LLC TRC	1,927	$31K	0.0%	+109.9%	0.004%
5/9/2023	GW&K Investment Management LLC	536,880	$8.62M	0.1%	N/A	0.994%
5/9/2023	Bank of New York Mellon Corp	422,789	$6.79M	0.0%	+20.2%	0.783%
5/9/2023	California State Teachers Retirement System	52,656	$0.85M	0.0%	-1.9%	0.098%
5/8/2023	Zurcher Kantonalbank Zurich Cantonalbank	7,868	$0.13M	0.0%	+8.7%	0.015%
5/4/2023	Barclays PLC	109,273	$1.76M	0.0%	+58.7%	0.203%
5/4/2023	Mirae Asset Global Investments Co. Ltd.	30,110	$0.48M	0.0%	+19.2%	0.056%
5/2/2023	Amalgamated Bank	5,709	$92K	0.0%	-18.1%	0.011%
4/28/2023	SG Americas Securities LLC	26,166	$0.42M	0.0%	+167.9%	0.049%
4/17/2023	Bourgeon Capital Management LLC	4,150	$67K	0.0%	+56.6%	0.008%
3/23/2023	MetLife Investment Management LLC	28,047	$0.51M	0.0%	+2.9%	0.052%
2/15/2023	MetLife Investment Management LLC	28,047	$0.51M	0.0%	+2.9%	0.052%
2/15/2023	Silverarc Capital Management LLC	152,747	$2.80M	0.8%	+2.5%	0.284%
2/15/2023	Sphera Funds Management LTD.	671,644	$12.29M	2.6%	+7.2%	1.250%
2/15/2023	State of Wisconsin Investment Board	35,794	$0.66M	0.0%	-6.0%	0.067%
2/15/2023	Legal & General Group Plc	15,946	$0.29M	0.0%	+4.5%	0.030%
2/15/2023	Millennium Management LLC	575,488	$10.53M	0.0%	+78.9%	1.071%
2/15/2023	Morgan Stanley	152,588	$2.79M	0.0%	+49.5%	0.284%
2/15/2023	First Light Asset Management LLC	1,329,313	$24.33M	2.3%	-1.3%	2.473%
2/15/2023	Alps Advisors Inc.	36,477	$0.67M	0.0%	+24.4%	0.068%
2/15/2023	Atom Investors LP	81,466	$1.49M	0.7%	+66.5%	0.152%
2/15/2023	Braidwell LP	3,469,674	$63.50M	2.1%	N/A	6.455%
2/14/2023	Point72 Asset Management L.P.	1,361,000	$24.91M	0.1%	+3.9%	2.532%
2/14/2023	Price T Rowe Associates Inc. MD	51,931	$0.95M	0.0%	-15.7%	0.097%
2/14/2023	Susquehanna International Group LLP	10,235	$0.19M	0.0%	-71.8%	0.019%
2/14/2023	Two Sigma Investments LP	24,612	$0.45M	0.0%	+5.8%	0.046%
2/14/2023	Driehaus Capital Management LLC	5,624,744	$102.93M	1.5%	-0.1%	10.465%
2/13/2023	First Republic Investment Management Inc.	19,216	$0.35M	0.0%	N/A	0.036%
2/13/2023	Charles Schwab Investment Management Inc.	343,055	$6.28M	0.0%	+2.0%	0.638%
2/13/2023	Deutsche Bank AG	29,257	$0.54M	0.0%	+35.9%	0.054%
2/13/2023	Barclays PLC	68,843	$1.26M	0.0%	+36.0%	0.128%
2/13/2023	Renaissance Technologies LLC	63,100	$1.16M	0.0%	N/A	0.117%
2/13/2023	Credit Suisse AG	29,682	$0.54M	0.0%	-4.5%	0.055%
2/13/2023	Martingale Asset Management L P	45,680	$0.84M	0.0%	N/A	0.085%
2/13/2023	Geode Capital Management LLC	921,230	$16.86M	0.0%	+4.3%	1.714%
2/13/2023	Finepoint Capital LP	822,745	$15.06M	4.9%	N/A	1.531%
2/13/2023	JPMorgan Chase & Co.	34,694	$0.64M	0.0%	+6.1%	0.065%
2/13/2023	Teacher Retirement System of Texas	11,350	$0.21M	0.0%	-7.5%	0.021%
2/10/2023	Opaleye Management Inc.	732,000	$13.40M	4.7%	+9.0%	1.362%
2/10/2023	Bank of America Corp DE	124,067	$2.27M	0.0%	+108.7%	0.231%
2/10/2023	Victory Capital Management Inc.	66,428	$1.22M	0.0%	-32.9%	0.123%
2/10/2023	Tekla Capital Management LLC	45,861	$0.84M	0.0%	N/A	0.085%
2/9/2023	Mirae Asset Global Investments Co. Ltd.	25,269	$0.46M	0.0%	+7.8%	0.047%
2/9/2023	Victory Capital Management Inc.	66,428	$1.22M	0.0%	-32.9%	0.124%
2/9/2023	Dimensional Fund Advisors LP	508,848	$9.31M	0.0%	-5.1%	0.947%
2/9/2023	Principal Financial Group Inc.	12,334	$0.23M	0.0%	N/A	0.023%
2/9/2023	Citigroup Inc.	48,871	$0.89M	0.0%	-30.7%	0.091%
2/9/2023	Saturn V Capital Management LLC	623,819	$11.34M	9.4%	N/A	1.161%
2/8/2023	UBS Group AG	80,694	$1.48M	0.0%	+891.4%	0.150%
2/8/2023	Swiss National Bank	90,800	$1.66M	0.0%	+3.2%	0.169%
2/3/2023	Fisher Asset Management LLC	76,924	$1.41M	0.0%	+44.2%	0.143%
2/2/2023	SG Americas Securities LLC	9,767	$0.18M	0.0%	-36.3%	0.018%
2/2/2023	ProShare Advisors LLC	11,222	$0.21M	0.0%	+8.9%	0.021%
2/2/2023	Monarch Partners Asset Management LLC	128,974	$2.36M	0.7%	-1.4%	0.240%
1/30/2023	Psagot Value Holdings Ltd. Israel	2,500	$46K	0.0%	N/A	0.005%
1/20/2023	Bourgeon Capital Management LLC	2,650	$48K	0.0%	N/A	0.005%
12/8/2022	Bank of New York Mellon Corp	341,482	$6.71M	0.0%	+3.1%	0.635%
11/22/2022	Teachers Retirement System of The State of Kentucky	44,989	$0.88M	0.0%	N/A	0.084%
11/21/2022	California State Teachers Retirement System	53,010	$1.04M	0.0%	-2.4%	0.099%
11/16/2022	BNP Paribas Arbitrage SNC	45,485	$0.89M	0.0%	+277.7%	0.085%
11/15/2022	State Street Corp	1,808,665	$35.52M	0.0%	+2.7%	3.365%
11/15/2022	Algert Global LLC	17,406	$0.34M	0.0%	-13.3%	0.032%

Data available starting January 2016

Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly. The firm is also developing other oral nonpeptide somatostatin agonists for neuroendocrine tumors and hyperinsulinism, as well as an oral nonpeptide ACTH antagonist for the treatment of Cushing's disease. The company was founded by R. Scott Struthers, Yun-Fei Zhu and Stephen F. Betz in 2008 and is headquartered in San Diego, CA.

Today's Range

Now: $21.85

$21.41

$22.12

50 Day Range

MA: $19.19

$15.31

$23.60

52 Week Range

Now: $21.85

$15.23

$24.58

Volume

444,344 shs

Average Volume

449,914 shs

Market Capitalization

$1.18 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.94

Who are the company insiders with the largest holdings of Crinetics Pharmaceuticals?: Crinetics Pharmaceuticals' top insider investors include:
Perceptive Advisors Llc (Major Shareholder)
Richard Scott Struthers (CEO)
Stephen F Betz (Insider)
Matthew K Fust (Director)
Jeff E Knight (COO)
Dana Pizzuti (Insider)
Ajay Madan (Insider)
Learn More about top insider investors at Crinetics Pharmaceuticals.
Who are the major institutional investors of Crinetics Pharmaceuticals?: Crinetics Pharmaceuticals' top institutional investors include:
BlackRock Inc. — 7.33%
Wellington Management Group LLP — 6.73%
Perceptive Advisors LLC — 6.58%
State Street Corp — 4.11%
Braidwell LP — 3.74%
First Light Asset Management LLC — 3.00%
Learn More about top institutional investors of Crinetics Pharmaceuticals stock.
Which institutional investors are selling Crinetics Pharmaceuticals stock?: During the previous quarter, CRNX stock was sold by these institutional investors:
Braidwell LP
FMR LLC
Sphera Funds Management LTD.
Perceptive Advisors LLC
Atom Investors LP
Dimensional Fund Advisors LP
Two Sigma Advisers LP
UBS Group AG
During the last year, company insiders that have sold Crinetics Pharmaceuticals company stock include:
Perceptive Advisors Llc (Major Shareholder)
Richard Scott Struthers (CEO)
Stephen F Betz (Insider)
Matthew K Fust (Director)
Learn More investors selling Crinetics Pharmaceuticals stock.
Which institutional investors are buying Crinetics Pharmaceuticals stock?: In the last quarter, CRNX stock was bought by institutional investors including:
Wellington Management Group LLP
GW&K Investment Management LLC
First Light Asset Management LLC
State Street Corp
ExodusPoint Capital Management LP
Franklin Resources Inc.
Saturn V Capital Management LLC
Altium Capital Management LP